You are here

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Last updated on April 18, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Renal Cell Carcinoma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Patients who are 18 year-old or over who have been treated for metastatic renal cell
carcinoma with sunitinib as first-line treatment (treatment with prior cytokine
therapy is accepted) between 2007 and 30 September 2018 and who have obtained as a
best treatment response the total remission of the disease in the opinion of the
doctor in charge from a clinical, radiological and/or macroscopic point of view. This
response must have been reached through two possible strategies:

A) Systemic treatment with sunitinib alone. B) Treatment with sunitinib and subsequent
local treatment for one or more residual lesions that have not responded to the drug
(traditional surgery, radiotherapy, SBRT (Stereotactic Body Radiation Therapy)).

2. The duration of CR must have been confirmed with at least 2 consecutive imaging tests,
without having a limit in the duration of this response. Although the patient had
progressed subsequently, he/she may be included in this registry.

3. Patients from any risk group

4. Tumours of any histology

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Patients treated with another drug other than Sunitinib.

2. Patients with no radiology reports proving CR.

3. Patients with no record of the dose and regimen received with Sunitinib.

4. Patients who achieved complete remission after 30 September 2018.

NCT03916458
Pfizer
Not yet recruiting
REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now